Filtros de búsqueda

Lista de obras de Alice Laroni

A case of thyroiditis during natalizumab therapy for multiple sclerosis

artículo científico publicado en 2011

A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study.

artículo científico publicado en 2018

Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells

artículo científico publicado en 2010

Approved drugs for multiple sclerosis: the challenge of choice

artículo científico publicado en 2017

Association of melanoma and natalizumab therapy in the Italian MS population: a second case report

article

Autologous hematopoietic stem cell transplantation in multiple sclerosis: A meta-analysis.

artículo científico publicado en 2017

CD56bright Natural Killer Cells: A Possible Biomarker of Different Treatments in Multiple Sclerosis

artículo científico publicado en 2020

COVID-19 in patients with multiple sclerosis undergoing disease-modifying treatments

scientific article published on 18 November 2020

Can we kill an extra bird with the same stone?

artículo científico publicado en 2011

Cardiovascular autonomic individual profile of relapsing-remitting multiple sclerosis patients and risk of extending cardiac monitoring after first dose fingolimod

scientific article published on 08 August 2019

Clinical baseline factors predict response to natalizumab: their usefulness in patient selection

artículo científico publicado en 2014

Clinical, laboratory features, and prognostic factors in adult acute transverse myelitis: an Italian multicenter study

scientific article published on 22 March 2019

Composite MRI measures and short-term disability in patients with clinically isolated syndrome suggestive of MS

artículo científico publicado en 2017

Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.

artículo científico publicado en 2015

Determinants of therapy switch in multiple sclerosis treatment-naïve patients: A real-life study

scientific article published on 25 July 2018

Dysregulation of regulatory CD56(bright) NK cells/T cells interactions in multiple sclerosis

artículo científico publicado en 2016

Enhancing natural killer cells is beneficial in multiple sclerosis - Yes

scientific article published on 13 November 2018

Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved?

scientific article published on 01 January 2020

Factors interfering with parenthood decision-making in an Italian sample of people with multiple sclerosis: an exploratory online survey

scientific article published on 16 January 2019

IL-27 Imparts Immunoregulatory Function to Human NK Cell Subsets ⬇️

artículo científico publicado el 19 de octubre de 2011

Impact of treatment on cellular immunophenotype in MS: A cross-sectional study

scientific article published on 05 March 2020

In vitro VLA-4 blockade results in an impaired NK cell-mediated immune surveillance against melanoma.

artículo científico publicado en 2016

Long-term disability progression in primary progressive multiple sclerosis: a 15-year study

artículo científico publicado en 2017

Magnetic Resonance Imaging Finding of Periodontal and Inferior Alveolar Nerve Inflammation in a Subject With Trigeminal Neuralgia

artículo científico publicado en 2020

Mesenchymal stem cells as treatment for MS - progress to date.

artículo científico publicado en 2012

Mesenchymal stem cells for the treatment of neurological diseases: Immunoregulation beyond neuroprotection

artículo científico

Neuroprotective features of mesenchymal stem cells.

artículo científico publicado en 2011

No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study

scientific article published on 26 September 2018

Outcomes after fingolimod to alemtuzumab treatment shift in relapsing-remitting MS patients: a multicentre cohort study

scientific article published on 17 June 2019

Overexpression of sphingosine-1-phosphate receptors on reactive astrocytes drives neuropathology of multiple sclerosis rebound after fingolimod discontinuation

artículo científico publicado en 2018

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks

artículo científico publicado en 2018

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks

artículo científico publicado en 2018

Regulatory Functions of Natural Killer Cells in Multiple Sclerosis.

artículo científico publicado en 2016

Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy

artículo científico publicado en 2016

Serum sickness (Like Reaction) in a patient treated with alemtuzumab for multiple sclerosis: A case report

scientific article published on 11 September 2018

Teriflunomide treatment reduces B cells in patients with MS.

artículo científico publicado en 2017

Three years of experience: the Italian registry and safety data update.

artículo científico publicado en 2011

Urinary JCV-DNA Testing during Natalizumab Treatment May Increase Accuracy of PML Risk Stratification

scientific article published on 16 May 2012

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda